# Arvinas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arvinas

- Industry: Pharmaceuticals
- Headquarters: New Haven, US
- Website: www.arvinas.com
- Total disclosed funding: $100M
- Latest round: Series C (Mar 29, 2018)
- Investors on record: 11

## About

Founded in 2013 and based in Connecticut, US, Arvinas, Inc. is a biopharmaceutical company that develops protein degradation therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases.

## Funding rounds

- Series C, Mar 29, 2018, $55M — OrbiMed Advisors, Canaan Partners, 5AM Ventures, New Leaf Venture Partners, Nextech, Hillhouse Investment, Deerfield Management, RA Capital Management, Sirona Capital
- Series B, Oct 21, 2015, $42M — OrbiMed Advisors, Canaan Partners, 5AM Ventures, New Leaf Venture Partners, Connecticut Innovations, Elm Street Ventures, RA Capital Management
- Series A, Jul 16, 2013, $3.5M — Canaan Partners, 5AM Ventures, Connecticut Innovations, Elm Street Ventures

## Investors

- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A, Series B, Series C
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A, Series B, Series C
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A, Series B
- Elm Street Ventures (https://capitalatlas.ai/funds/elm-street-ventures) — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B, Series C
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B, Series C
- Nextech (https://capitalatlas.ai/funds/nextech) — Series C
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series C
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series C
- Sirona Capital (https://capitalatlas.ai/funds/sirona-capital) — Series C